Find guidance show guidance menu

CG78 Borderline personality disorder (BPD): full guideline

This page was last updated: 14 September 2010

Selected, reliable information for health and social care in one place

NICE on Twitter

@NICEcomms
Follow @NICEcomms on Twitter
Subscribe to NICE
Share NICE
- - Evidence summaries: new medicines
  - Summaries of the best available evidence for selected new medicines, or for existing medicines with new indications, to inform local NHS planning and decision-making.
  - Find out more
  - Evidence summaries: unlicensed/off-label meds
  - A new service providing summaries of the best available evidence on selected unlicensed and off-label medicines, designed to meet demand for information to inform local NHS planning and decision-making.
  - Find out more
  - Medicines management guidance
  - Advice to support best practice in medicines management and use in the NHS, including good practice guides on developing local medicines formularies.
  - Find out more
  - Coming soon
  - Medicines evidence commentaries - Losartan or Candesartan in heart failure; Metformin in type 2 diabetes.
    
    Evidence summaries: new medicines - Fidaxomicin for Clostridium difficile infection
    
    Evidence summaries: unlicensed and off-label medicines - tranexamic acid for major haemorrhage
- - Events
  - Our programme of national events for medicines managers and prescribers, free of charge for NHS staff in England.
  - Find out more
  - Communities of practice
  - Support for communities of practice including controlled drugs, new medicines, local decision making and medicines and prescribing trainers and facilitators.
  - Find out more
  - Alerts
  - Sign up for and manage your subscriptions for a range of medicines and prescribing bulletins and alerts.
  - Find out more
  - British National Formulary
  - NICE is responsible for providing access for the NHS to the British National Formulary.
  - Find out more